Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of IGM Biosciences Inc (NASDAQ: IGMS) was $1.69 for the day, down -1.74% from the previous closing price of $1.72. In other words, the price has decreased by -$1.74 from its previous closing price. On the day, 0.57 million shares were traded. IGMS stock price reached its highest trading level at $1.78 during the session, while it also had its lowest trading level at $1.635.
Ratios:
Our analysis of IGMS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.22 and its Current Ratio is at 5.22. In the meantime, Its Debt-to-Equity ratio is 0.58 whereas as Long-Term Debt/Eq ratio is at 0.50.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on January 10, 2025, Downgraded its rating to Hold and sets its target price to $2.50 from $27 previously.
On January 10, 2025, RBC Capital Mkts Downgraded its rating to Sector Perform which previously was Outperform and also lowered its target price recommendation from $20 to $1.50.
Morgan Stanley Downgraded its Equal-Weight to Underweight on January 10, 2025, whereas the target price for the stock was revised from $12 to $2.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 15 ’25 when Weber Steven sold 1,122 shares for $1.70 per share. The transaction valued at 1,907 led to the insider holds 30,582 shares of the business.
Weber Steven sold 539 shares of IGMS for $4,032 on Dec 16 ’24. The PRINCIPAL ACCOUNTING OFFICER now owns 31,704 shares after completing the transaction at $7.48 per share. On Dec 16 ’24, another insider, Decker Lisa Lynn, who serves as the CHIEF BUSINESS OFFICER of the company, sold 1,063 shares for $7.48 each. As a result, the insider received 7,951 and left with 78,041 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IGMS now has a Market Capitalization of 100494504 and an Enterprise Value of -72435536. For the stock, the TTM Price-to-Sale (P/S) ratio is 34.41 while its Price-to-Book (P/B) ratio in mrq is 1.27. Its current Enterprise Value per Revenue stands at -24.824 whereas that against EBITDA is 0.323.
Stock Price History:
The Beta on a monthly basis for IGMS is -0.04, which has changed by -0.84264433 over the last 52 weeks, in comparison to a change of 0.23809385 over the same period for the S&P500. Over the past 52 weeks, IGMS has reached a high of $22.50, while it has fallen to a 52-week low of $1.59. The 50-Day Moving Average of the stock is -76.54%, while the 200-Day Moving Average is calculated to be -83.07%.
Shares Statistics:
IGMS traded an average of 423.63K shares per day over the past three months and 1445830 shares per day over the past ten days. A total of 34.06M shares are outstanding, with a floating share count of 17.59M. Insiders hold about 70.43% of the company’s shares, while institutions hold 30.69% stake in the company. Shares short for IGMS as of 1735603200 were 2511803 with a Short Ratio of 5.93, compared to 1732838400 on 2703497. Therefore, it implies a Short% of Shares Outstanding of 2511803 and a Short% of Float of 16.510001.
